#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer extensive stage Eosinophilic granulomatosis with polyangiitis Fms-like tyrosine kinase 3 positive Neonatal alloimmune thrombocytopenia Chronic kidney disease Lung adenocarcinoma Vernal keratoconjunctivitis Haemolytic uraemic syndrome HER2 mutant non-small cell lung cancer Autoimmune hepatitis Adrenogenital syndrome Cutaneous calcification Small intestine leiomyosarcoma Laryngeal squamous cell carcinoma Tuberous sclerosis complex More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Immunodeficiency congenital – Trials in Disease Alport’s syndrome Lennox-Gastaut syndrome – Diagnostics Niemann-Pick disease – Trials in Disease Soft tissue sarcoma Nephrotic syndrome – Life with Disease Lymphangioma – Treatment Choroid melanoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ferric Carboxymaltose Bosutinib Pelareorep SARACATINIB Tisotumab Vedotin Bay 2927088 Tramadol Hydrochloride Pegipanermin Jk06 Retinol Palmitate Daridorexant Pegunigalsidase Alfa Peginterferon Beta-1A GLYCYL-TYROSINE Ixekizumab Abrocitinib Faricimab GSKVX000000030825 Infliximab Exenatide More therapies…

    Learn about Your Condition

    Spinal muscular atrophy Cervix carcinoma Epstein-Barr virus infection Choroid melanoma Erythema migrans Intestinal ischaemia Epilepsy Wheezing Carotid artery occlusion Emphysema Microvillous inclusion disease Vertebrobasilar stroke Alexander disease Polycystic liver disease Drug dependence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • BRAF gene mutation
    Investigated Drugs:
    • (3R)-N-[3-[5-(2-Cyclopropylpyrimidin-5-Yl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl]-3-Fluoropyrrolidine-1-Sulfonamide
    • Cobicistat
    France Germany Italy The Netherlands Norway Spain +1

  • Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Austria Germany Portugal

  • Study on Treating Postoperative Anemia in Older Cardiac Surgery Patients with Ferric Derisomaltose and Sodium Chloride

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency anaemia
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    The Netherlands

  • Study on Using Fluorescein Sodium to Identify Inflammation in Crohn’s Disease Patients During Ileal Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Fluorescein Sodium
    France

  • Study on the Effects of Rituximab and Cyclophosphamide in Patients with ANCA Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Cyclophosphamide
    • Rituximab
    The Netherlands

  • Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Letrozole
    Austria Germany
Previous Page
1 … 347 348 349 350 351 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!